68 related articles for article (PubMed ID: 33803861)
1. 8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for in vivo imaging of the A
Humpert S; Schneider D; Bier D; Schulze A; Neumaier F; Neumaier B; Holschbach M
Eur J Med Chem; 2024 May; 271():116380. PubMed ID: 38615410
[TBL] [Abstract][Full Text] [Related]
2. Development of the High-Affinity Carborane-Based Cannabinoid Receptor Type 2 PET Ligand [
Ueberham L; Gündel D; Kellert M; Deuther-Conrad W; Ludwig FA; Lönnecke P; Kazimir A; Kopka K; Brust P; Moldovan RP; Hey-Hawkins E
J Med Chem; 2023 Apr; 66(7):5242-5260. PubMed ID: 36944112
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Singh SS
Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
[TBL] [Abstract][Full Text] [Related]
4. Species Differences in Microsomal Metabolism of Xanthine-Derived A
Schneider D; Bier D; Holschbach M; Bauer A; Neumaier B
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33803861
[TBL] [Abstract][Full Text] [Related]
5. New potent A
Kreft S; Bier D; Holschbach MH; Schulze A; Coenen HH
Nucl Med Biol; 2017 Jan; 44():69-77. PubMed ID: 27821347
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 18F-CPFPX, a novel adenosine A1 receptor ligand: in vitro autoradiography and high-resolution small animal PET.
Bauer A; Holschbach MH; Cremer M; Weber S; Boy C; Shah NJ; Olsson RA; Halling H; Coenen HH; Zilles K
J Nucl Med; 2003 Oct; 44(10):1682-9. PubMed ID: 14530487
[TBL] [Abstract][Full Text] [Related]
7. Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A
Schneider D; Oskamp A; Holschbach M; Neumaier B; Bier D; Bauer A
Nucl Med Biol; 2020; 82-83():1-8. PubMed ID: 31838339
[TBL] [Abstract][Full Text] [Related]
8. Relevance of In Vitro Metabolism Models to PET Radiotracer Development: Prediction of In Vivo Clearance in Rats from Microsomal Stability Data.
Schneider D; Oskamp A; Holschbach M; Neumaier B; Bauer A; Bier D
Pharmaceuticals (Basel); 2019 Apr; 12(2):. PubMed ID: 31013984
[TBL] [Abstract][Full Text] [Related]
9. Influence of incubation conditions on microsomal metabolism of xanthine-derived A
Schneider D; Bier D; Bauer A; Neumaier B; Holschbach M
J Pharmacol Toxicol Methods; 2019; 95():16-26. PubMed ID: 30476620
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Pharmacological Evaluation of Identified and Putative Metabolites of the A
Holschbach MH; Bier D; Sihver W; Schulze A; Neumaier B
ChemMedChem; 2017 May; 12(10):770-784. PubMed ID: 28217962
[TBL] [Abstract][Full Text] [Related]
11. Species differences in hepatic and intestinal metabolic activities for 43 human cytochrome P450 substrates between humans and rats or dogs.
Nishimuta H; Nakagawa T; Nomura N; Yabuki M
Xenobiotica; 2013 Nov; 43(11):948-55. PubMed ID: 23593983
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]